Publications by authors named "A Poprach"

Claim this Profile
E
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort.
Ondrej Fiala, Francesco Grillone, Kazutoshi Fujita, Enrique Grande, Patrizia Giannatempo, Alexandr Poprach

Eur Urol Open Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study.
Miroslav Světlák, Michal Standara, Tatiana Malatincová, Michal Staník, David Miklánek, Alexandr Poprach

Front Public Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab.
Ondřej Fiala, Katarína Rejleková, Tomas Buchler, Hana Študentová, Alexandr Poprach

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2 project.
Alessandro Rizzo, Zin W Myint, Francesco Ciccimarra, Anca Zgura, Marc R Matrana, Alexandr Poprach

Clin Exp Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study.
Renate Pichler, Gerald Klinglmair, Kirstin Binz, Enrique Grande, Alina Pirshtuk, Alexandr Poprach

Clin Exp Metastasis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis